TipRanks
Go Ultimate55% OFF

Declan Doogan Insider Profile

4 Followers

Declan Doogan, Director at Tenax Therapeutics, holds 55.27K shares in Tenax Therapeutics (Ticker: TENX), holds 1.50M shares in Biohaven Pharmaceutical Holding Co (Ticker: ~BHVN), holds 1.52M shares in Biohaven Ltd. (Ticker: BHVN). Most recently, Declan Doogan Bought ― shares of Tenax Therapeutics on Sep 17, 2026 for an estimated value of $101.76K.

Declan Doogan's Trading History

TENX
Tenax Therapeutics
Sep 17, 2026DirectorInformative Buy101.76K$98.94K
~BHVN
Biohaven Pharmaceutical Holding Co
Dec 01, 2021―Informative Sell2.77M$227.19M
BHVN
Biohaven Ltd.
Nov 17, 2021DirectorUninformative Buy4.40M$23.46M

You May Also Like

Declan Doogan insider profile FAQ

What stocks does Declan Doogan hold?
Declan Doogan holds: TENX, ~BHVN, BHVN stocks.
What was Declan Doogan’s latest transaction?
Declan Doogan’s latest transaction was an Informative Buy of $101.76K.
What was Declan Doogan's most profitable transaction?
Declan Doogan’s most profitable transaction was an Informative Buy of TENX stock on September 17, 2026. The return on the trade was -3.70%.
What is Declan Doogan's role in Tenax Therapeutics?
Declan Doogan's role in Tenax Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.